# V1 Empirics Check — qwen/qwen3.5-397b-a17b (Variant C)

**Model:** qwen/qwen3.5-397b-a17b
**Variant:** C
**Date:** 2026-03-25T16:21:13.414018

---

## Review: "The Safety Valve Lottery: Judge Discretion, the First Step Act, and Racial Equity in Federal Drug Sentencing"

### 1. Idea Fidelity

The paper deviates significantly from the manifest in several critical ways. First, the manifest proposes a **judge-leniency IV with triple-difference design** using leave-one-out mean safety valve utilization as an instrument, exploiting random case assignment to judges. The submitted paper instead implements a standard **difference-in-differences** with no instrumental variables and no judge-level variation. Second, the manifest emphasizes the JUSTFAIR dataset for judge identifiers; the paper mentions judge fixed effects only in passing ("where available") without using the judge-level data that was central to the original design. Third, the manifest's triple-difference (pre/post × newly/already eligible × judge leniency) is reduced to a simpler DiD with racial heterogeneity. These are not minor modifications—they fundamentally change the identification strategy and the paper's contribution to the judicial discretion literature.

### 2. Summary

This paper examines whether the First Step Act's safety valve expansion reduced federal drug sentences and racial disparities using USSC data from FY2016–FY2024. The authors find modest sentence reductions for newly eligible defendants with heterogeneous effects by race, though several empirical results raise concerns about specification and interpretation.

### 3. Essential Points

**1. Critical sign errors in the main tables undermine credibility.** Table 2 reports the effect of FSA on safety valve application as negative (−0.343, −0.300), implying newly eligible defendants were *less* likely to receive safety valve relief after the expansion. This contradicts the policy's intent and the paper's own narrative. Before FSA, newly eligible defendants had zero access to the safety valve by definition; after FSA, utilization should increase substantially. Similarly, Table 1 shows the sentence length coefficient flipping from positive (1.08, 0.56) to negative (−0.35) as controls are added, with the "preferred specification" (column 4) reported as "NA." These inconsistencies suggest either coding errors or severe specification instability that must be resolved before the results can be interpreted.

**2. The identification strategy lacks the judge-level variation promised in the manifest.** The manifest's core contribution was using judge assignment randomness to instrument for safety valve utilization, following Yang (2015). This would have allowed the authors to separate judicial discretion from prosecutorial charging decisions. The submitted DiD design cannot distinguish whether sentence reductions reflect judicial behavior or prosecutor responses (e.g., plea bargaining adjustments). Without the judge IV, the paper cannot answer its central question about whether expanded *judicial* discretion reduces disparities. The district-level clustering is appropriate but does not recover judicial discretion effects.

**3. Key validation evidence is missing.** The paper describes an event-study specification (equation 2) to test parallel trends but never presents the event-study graph or coefficients. This is the primary evidence for the DiD identifying assumption. Similarly, the Pulsifer validity check is mentioned but Table 4 shows only a single coefficient (0.05, SE 0.83) with no clear comparison group or pre/post breakdown. Without these diagnostics, readers cannot assess whether the estimated effects reflect the policy or confounded trends.

### 4. Suggestions

**Clarify and correct the empirical results.** Before any substantive interpretation, the authors must reconcile the sign inconsistencies in Tables 1 and 2. If the safety valve coefficient should be positive (as theory dictates), this needs to be corrected throughout. The "NA" in Table 1 column 4 should either be populated or that column removed. I recommend the authors re-run all regressions from scratch, verify variable coding (particularly the treatment indicator and outcome construction), and report a single, coherent specification as the main result. A transparency appendix with replication code would help.

**Present the event-study evidence.** The parallel trends assumption is the linchpin of the DiD design. Include a figure showing the treatment effect coefficients by fiscal year relative to FY2018 (the omitted baseline), with confidence intervals. This serves two purposes: (1) it demonstrates whether pre-trends are flat, and (2) it shows the dynamic response to the policy. If pre-trends are not parallel, the authors should acknowledge this limitation and consider alternative identification strategies (e.g., synthetic control, regression discontinuity around the criminal history cutoff).

**Either implement the judge IV or reframe the contribution.** If the authors wish to maintain the judicial discretion focus, they should use the JUSTFAIR judge identifiers to construct leave-one-out judge leniency measures and implement the IV strategy from the manifest. This would require merging USSC data with JUSTFAIR judge IDs and estimating a two-stage least squares model where the instrument is the judge's historical safety valve rate (excluding the current case). If this is not feasible, the paper should be reframed as a policy evaluation of the FSA's aggregate effects rather than a study of judicial behavior. The current title and abstract overclaim the judicial discretion angle.

**Improve the magnitude interpretation.** The reported sentence reduction of −0.35 months (Table 1) is economically trivial—about 10 days. Yet the text claims "thousands of person-years of incarceration annually." These statements are inconsistent. If the effect is truly −0.35 months per defendant and there are 1,400 newly eligible defendants per year, that is approximately 40 person-years, not thousands. The authors should either (a) report effects in more interpretable units (e.g., percentage reduction from baseline), or (b) clarify whether the effect is larger for specific subgroups (e.g., those facing the longest mandatory minimums). Table A1 shows heterogeneous effects by race with larger magnitudes (−6.10 months for Black defendants), which should be highlighted as the main finding if robust.

**Strengthen the Pulsifer validity check.** The Pulsifer reversal is a clever natural experiment, but the current presentation is underpowered. The authors should: (1) clearly define the affected population (which criminal history profiles were re-excluded?), (2) show a triple-difference comparing affected vs. unaffected defendants before vs. after Pulsifer, and (3) acknowledge the limited post-Pulsifer data (only a few months of FY2024). If the sample is too small for definitive conclusions, frame it as preliminary evidence rather than a "strongest validation."

**Address the control group contamination concern.** The control group (criminal history 0–1 points) was eligible for the safety valve both before and after FSA. However, the FSA also included other provisions (e.g., retroactive Fair Sentencing Act application) that could affect this group. The authors mention this but do not fully address it. A cleaner design might use defendants with 5+ criminal history points as an additional control group (never eligible for safety valve), or focus on a regression discontinuity around the 4-point cutoff.

**Clarify the clustering and inference.** District-level clustering is appropriate, but with 94 districts and a national policy change, there is a risk of few-cluster bias. The authors should report the number of districts with treated observations and consider wild bootstrap inference or reporting Conley spatial SEs as robustness checks. Additionally, the standard errors in Table 3 (racial heterogeneity) appear small relative to the effect sizes—verify that the clustering is correctly implemented in the triple-interaction specification.

**Improve the institutional detail.** The paper would benefit from a clearer timeline figure showing FSA enactment (December 2018), implementation, and Pulsifer (June 2024) relative to the fiscal year data structure. Also clarify whether FY2019 includes cases from October 2018–September 2019, which would mean some pre-FSA cases are coded as post-FSA. This timing ambiguity could attenuate estimates.

**Consider alternative outcomes.** The paper focuses on sentence length and safety valve application. Given the data, the authors could also examine: (1) plea rates (does expanded discretion affect guilty plea decisions?), (2) prosecutorial charging (do mandatory minimum charges decline post-FSA?), and (3) recidivism (available in USSC data for older cohorts). These would strengthen the policy implications.

**Tone down the claims.** The conclusion states the reform "worked as intended" and that benefits "were not shared equally." Given the empirical issues noted above, these claims should be more cautious. A more defensible conclusion would acknowledge the identification limitations and frame the results as suggestive evidence requiring further validation with judge-level data.

---

**Bottom line:** This paper addresses an important policy question with valuable data, but the empirical execution has significant problems that must be addressed before the results can be trusted. The sign errors in the main tables are disqualifying as written. If the authors can correct these issues, implement the judge IV from the manifest (or reframe appropriately), and present the event-study evidence, this could be a useful contribution to the sentencing literature. As submitted, I cannot recommend acceptance without major revisions.
